| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |